RxDoctor Payments Data

Erika Powell

Physician Assistant · Princeton, WVNPI 1629201025

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 287 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,792 and has fallen 58.8% since, to $738 in 2025. Among physician assistant clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,523in general payments, 2019–2025

Across 287 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$640
  • Novo Nordisk$506
  • GSK$329
  • Boehringer Ingelheim$262
  • Amgen$222
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$4,523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,523 in reported general payments places this provider in the 90th percentile of 833 physician assistant providers in West Virginia.

See all physician assistant providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide73$104,664
FarxigaDapagliflozin Propanediol41$39,437
JardianceEmpagliflozin31$32,031
EliquisApixaban37$30,887
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$14,469
JanuviaSitagliptin Phosphate15$12,856
XareltoRivaroxaban17$12,331
MounjaroTirzepatide12$12,003
MyrbetriqMirabegron11$8,548
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$8,194
Dexlansoprazole DrDexlansoprazole16$5,708
Lantus SolostarInsulin Glargine,hum.Rec.Anlog37$5,017
FenofibrateFenofibrate Nanocrystallized26$1,408
Ventolin HfaAlbuterol Sulfate12$1,072
Albuterol Sulfate HfaAlbuterol Sulfate40$1,019

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$506$104,66473 claims
AstraZenecaFarxiga, Breztri Aerosphere$1,054$47,63154 claims
Boehringer IngelheimJardiance$262$32,03131 claims
PfizerEliquis$164$30,88737 claims
GSKTrelegy Ellipta$329$14,46919 claims
MerckJanuvia$166$12,85615 claims
Johnson & JohnsonXarelto$61$12,33117 claims
Lilly USA, LLCMounjaro$191$12,00312 claims
Almatica Pharma LLCSertraline Hcl$23$26323 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 833 physician assistant providers in West Virginia.

Other physician assistant in Princeton

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →